Coping After Breast Cancer - a Randomized Clinical Trial With Two Digital Interventions

Recruiting N/A Interventional Study
Breast Cancer Patients Health, Subjective
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
20 – 69
Sex
Female
Study type
Interventional
Purpose
Prevention
Participants needed
390 (estimated)
Sponsor
Norwegian Institute of Public Health · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
1. Breast cancer patients and age-matched controls are first invited to answer questions on HRQoL. 2. Among responding breast cancer patients, a subset are invited in a randomized clinical trial with two digital interventions for cancer stress management, cognitive based stress management (CBSM) and mindfulness based intervention (MBI), as well as a control group. 3. The goal is to determine wheth…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * first occurrence breast cancer diagnosed from Jan 1, 2020 * non-metastatic cancer stage 0-III Invasive tumors must be: * HER2 positive (regardless of ER, PR) or * ER negative * (may later include other ER+ if not conflict with recruitment for EMIT/OPTIMA) Exclusion Criteria…
Contacts

Giske Ursin, MD, PhD

+4722451300

giske.ursin@kreftregisteret.no

CONTACT

Ine M Larsson

+4722928985

ine.marie.larsson@kreftregisteret.no

CONTACT